Optimizing treatment for relapsed/refractory classic hodgkin lymphoma in the era of immunotherapy
MP Randall, MA Spinner - Cancers, 2023 - mdpi.com
Simple Summary Classic Hodgkin lymphoma (cHL) has a high cure rate with chemotherapy,
but 10–30% of patients experience relapse or refractory (R/R) disease, depending on stage …
but 10–30% of patients experience relapse or refractory (R/R) disease, depending on stage …